The Role of Ketogenic Metabolic Therapy on the Brain in Serious Mental Illness: A Review
Authors:
Open Access
- 31 October 2022
- journal article
- review article
- Published by Hapres in Journal of Psychiatry and Brain Science
- Vol. 7 (5)
Abstract
In search of interventions targeting brain dysfunction and underlying cognitive impairment in schizophrenia, we look at the brain and beyond to the potential role of dysfunctional systemic metabolism on neural network instability and insulin resistance in serious mental illness. We note that disrupted insulin and cerebral glucose metabolism are seen even in medication-naïve first-episode schizophrenia, suggesting that people with schizophrenia are at risk for Type 2 diabetes and cardiovascular disease, resulting in a shortened life span. Although glucose is the brain’s default fuel, ketones are a more efficient fuel for the brain. We highlight evidence that a ketogenic diet can improve both the metabolic and neural stability profiles. Specifically, a ketogenic diet improves mitochondrial metabolism, neurotransmitter function, oxidative stress/inflammation, while also increasing neural network stability and cognitive function. To reverse the neurodegenerative process, increasing the brain’s access to ketone bodies may be needed. We describe evidence that metabolic, neuroprotective, and neurochemical benefits of a ketogenic diet potentially provide symptomatic relief to people with schizophrenia while also improving their cardiovascular or metabolic health. We review evidence for KD side effects and note that although high in fat it improves various cardiovascular and metabolic risk markers in overweight/obese individuals. We conclude by calling for controlled clinical trials to confirm or refute the findings from anecdotal and case reports to address the potential beneficial effects of the ketogenic diet in people with serious mental illness.Keywords
This publication has 110 references indexed in Scilit:
- Multilocus loss of DNA methylation in individuals with mutations in the histone H3 Lysine 4 Demethylase KDM5CBMC Medical Genomics, 2013
- Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)The Journal of Clinical Psychiatry, 2012
- Epilepsy as a Neurodevelopmental DisorderFrontiers in Psychiatry, 2012
- Noninvasive Functional and Structural Connectivity Mapping of the Human Thalamocortical SystemCerebral Cortex, 2009
- Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of DementiaJAMA, 2009
- Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literatureNutrition & Metabolism, 2009
- Is Schizophrenia a Syndrome of Accelerated Aging?Schizophrenia Bulletin, 2008
- Factors that Influence Adherence to a Gluten-Free Diet in Adults with Celiac DiseaseDigestive Diseases and Sciences, 2007
- Anticonvulsant Mechanisms of the Ketogenic DietEpilepsia, 2007
- The ketogenic diet may have mood-stabilizing propertiesMedical Hypotheses, 2001